Agios Pharmaceuticals (AGIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 770,248 | -177,667 | -81,549 | -352,088 | -256,148 |
| Depreciation Amortization | -4,584 | -2,195 | -1,179 | 1,572 | 562 |
| Accounts receivable | -308 | -952 | -643 | -604 | 1,030 |
| Accounts payable and accrued liabilities | 7,357 | 268 | 1,430 | -8,733 | -5,201 |
| Other Working Capital | 26,493 | -18,860 | -28,985 | -19,057 | -24,657 |
| Other Operating Activity | -1,055,880 | 26,950 | 11,059 | 82,848 | 60,840 |
| Operating Cash Flow | $-256,674 | $-172,456 | $-99,867 | $-296,062 | $-223,574 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -678 | -259 | -101 | 326 | 560 |
| Purchase Of Investment | -1,344,107 | -348,604 | -244,059 | -417,930 | -327,490 |
| Sale Of Investment | 868,248 | 510,669 | 368,722 | 674,679 | 488,492 |
| Other Investing Activity | 889,136 | 0 | 0 | -17,500 | -17,500 |
| Investing Cash Flow | $412,599 | $161,806 | $124,562 | $239,575 | $144,062 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 9,600 | 6,963 | 5,864 | 5,433 | 4,586 |
| Financing Cash Flow | $9,600 | $6,963 | $5,864 | $5,433 | $4,586 |
| Beginning Cash Position | 88,205 | 88,205 | 88,205 | 139,259 | 139,259 |
| End Cash Position | 253,730 | 84,518 | 118,764 | 88,205 | 64,333 |
| Net Cash Flow | $165,525 | $-3,687 | $30,559 | $-51,054 | $-74,926 |
| Free Cash Flow | |||||
| Operating Cash Flow | -256,674 | -172,456 | -99,867 | -296,062 | -223,574 |
| Capital Expenditure | -718 | -299 | -141 | -999 | -765 |
| Free Cash Flow | -257,392 | -172,755 | -100,008 | -297,061 | -224,339 |